Literature DB >> 24874546

A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.

Mark Estacion1, Janelle E O'Brien2, Allison Conravey3, Michael F Hammer4, Stephen G Waxman1, Sulayman D Dib-Hajj5, Miriam H Meisler6.   

Abstract

Rare de novo mutations of sodium channels are thought to be an important cause of sporadic epilepsy. The well established role of de novo mutations of sodium channel SCN1A in Dravet Syndrome supports this view, but the etiology of many cases of epileptic encephalopathy remains unknown. We sought to identify the genetic cause in a patient with early onset epileptic encephalopathy by whole exome sequencing of genomic DNA. The heterozygous mutation c. 2003C>T in SCN8A, the gene encoding sodium channel Nav1.6, was detected in the patient but was not present in either parent. The resulting missense substitution, p.Thr767Ile, alters an evolutionarily conserved residue in the first transmembrane segment of channel domain II. The electrophysiological effects of this mutation were assessed in neuronal cells transfected with mutant or wildtype cDNA. The mutation causes enhanced channel activation, with a 10mV depolarizing shift in voltage dependence of activation as well as increased ramp current. In addition, pyramidal hippocampal neurons expressing the mutant channel exhibit increased spontaneous firing with PDS-like complexes as well as increased frequency of evoked action potentials. The identification of this new gain-of-function mutation of Nav1.6 supports the inclusion of SCN8A as a causative gene in infantile epilepsy, demonstrates a novel mechanism for hyperactivity of Nav1.6, and further expands the role of de novo mutations in severe epilepsy.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  De novo mutation; Epilepsy; Epileptic encephalopathy; Sodium channel

Mesh:

Substances:

Year:  2014        PMID: 24874546      PMCID: PMC4124819          DOI: 10.1016/j.nbd.2014.05.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  51 in total

1.  Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses.

Authors:  J H Caldwell; K L Schaller; R S Lasher; E Peles; S R Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 2.  Allelic mutations of the sodium channel SCN8A reveal multiple cellular and physiological functions.

Authors:  Miriam H Meisler; Nicholas W Plummer; Daniel L Burgess; David A Buchner; Leslie K Sprunger
Journal:  Genetica       Date:  2004-09       Impact factor: 1.082

3.  Role of axonal NaV1.6 sodium channels in action potential initiation of CA1 pyramidal neurons.

Authors:  Michel Royeck; Marie-Therese Horstmann; Stefan Remy; Margit Reitze; Yoel Yaari; Heinz Beck
Journal:  J Neurophysiol       Date:  2008-07-23       Impact factor: 2.714

4.  De novo SCN8A mutation identified by whole-exome sequencing in a boy with neonatal epileptic encephalopathy, multiple congenital anomalies, and movement disorders.

Authors:  Ulvi Vaher; Margit Nõukas; Tiit Nikopensius; Mart Kals; Tarmo Annilo; Mari Nelis; Katrin Ounap; Tiia Reimand; Inga Talvik; Pilvi Ilves; Andres Piirsoo; Enn Seppet; Andres Metspalu; Tiina Talvik
Journal:  J Child Neurol       Date:  2013-12-18       Impact factor: 1.987

5.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.

Authors:  Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall
Journal:  Nat Neurosci       Date:  2006-08-20       Impact factor: 24.884

6.  Altered subthreshold sodium currents and disrupted firing patterns in Purkinje neurons of Scn8a mutant mice.

Authors:  I M Raman; L K Sprunger; M H Meisler; B P Bean
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

7.  SCN1A testing for epilepsy: application in clinical practice.

Authors:  Shinichi Hirose; Ingrid E Scheffer; Carla Marini; Peter De Jonghe; Eva Andermann; Alica M Goldman; Marcelo Kauffman; Nigel C K Tan; Daniel H Lowenstein; Sanjay M Sisodiya; Ruth Ottman; Samuel F Berkovic
Journal:  Epilepsia       Date:  2013-04-15       Impact factor: 5.864

8.  Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy.

Authors:  Katherine D Holland; Jennifer A Kearney; Tracy A Glauser; Gerri Buck; Mehdi Keddache; John R Blankston; Ian W Glaaser; Robert S Kass; Miriam H Meisler
Journal:  Neurosci Lett       Date:  2008-01-11       Impact factor: 3.046

9.  Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice.

Authors:  Wenzhi Sun; Jacy L Wagnon; Connie L Mahaffey; Michael Briese; Jernej Ule; Wayne N Frankel
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

10.  De novo mutations in epileptic encephalopathies.

Authors:  Andrew S Allen; Samuel F Berkovic; Patrick Cossette; Norman Delanty; Dennis Dlugos; Evan E Eichler; Michael P Epstein; Tracy Glauser; David B Goldstein; Yujun Han; Erin L Heinzen; Yuki Hitomi; Katherine B Howell; Michael R Johnson; Ruben Kuzniecky; Daniel H Lowenstein; Yi-Fan Lu; Maura R Z Madou; Anthony G Marson; Heather C Mefford; Sahar Esmaeeli Nieh; Terence J O'Brien; Ruth Ottman; Slavé Petrovski; Annapurna Poduri; Elizabeth K Ruzzo; Ingrid E Scheffer; Elliott H Sherr; Christopher J Yuskaitis; Bassel Abou-Khalil; Brian K Alldredge; Jocelyn F Bautista; Samuel F Berkovic; Alex Boro; Gregory D Cascino; Damian Consalvo; Patricia Crumrine; Orrin Devinsky; Dennis Dlugos; Michael P Epstein; Miguel Fiol; Nathan B Fountain; Jacqueline French; Daniel Friedman; Eric B Geller; Tracy Glauser; Simon Glynn; Sheryl R Haut; Jean Hayward; Sandra L Helmers; Sucheta Joshi; Andres Kanner; Heidi E Kirsch; Robert C Knowlton; Eric H Kossoff; Rachel Kuperman; Ruben Kuzniecky; Daniel H Lowenstein; Shannon M McGuire; Paul V Motika; Edward J Novotny; Ruth Ottman; Juliann M Paolicchi; Jack M Parent; Kristen Park; Annapurna Poduri; Ingrid E Scheffer; Renée A Shellhaas; Elliott H Sherr; Jerry J Shih; Rani Singh; Joseph Sirven; Michael C Smith; Joseph Sullivan; Liu Lin Thio; Anu Venkat; Eileen P G Vining; Gretchen K Von Allmen; Judith L Weisenberg; Peter Widdess-Walsh; Melodie R Winawer
Journal:  Nature       Date:  2013-08-11       Impact factor: 49.962

View more
  52 in total

1.  Precision Medicine: SCN8A Encephalopathy Treated with Sodium Channel Blockers.

Authors:  Rikke S Møller; Katrine M Johannesen
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  Neuronal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy.

Authors:  Luis F Lopez-Santiago; Yukun Yuan; Jacy L Wagnon; Jacob M Hull; Chad R Frasier; Heather A O'Malley; Miriam H Meisler; Lori L Isom
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

3.  Gain-of-function FHF1 mutation causes early-onset epileptic encephalopathy with cerebellar atrophy.

Authors:  Aleksandra Siekierska; Mala Isrie; Yue Liu; Chloë Scheldeman; Niels Vanthillo; Lieven Lagae; Peter A M de Witte; Hilde Van Esch; Mitchell Goldfarb; Gunnar M Buyse
Journal:  Neurology       Date:  2016-05-04       Impact factor: 9.910

4.  SCN8A encephalopathy: Research progress and prospects.

Authors:  Miriam H Meisler; Guy Helman; Michael F Hammer; Brandy E Fureman; William D Gaillard; Alan L Goldin; Shinichi Hirose; Atsushi Ishii; Barbara L Kroner; Christoph Lossin; Heather C Mefford; Jack M Parent; Manoj Patel; John Schreiber; Randall Stewart; Vicky Whittemore; Karen Wilcox; Jacy L Wagnon; Phillip L Pearl; Adeline Vanderver; Ingrid E Scheffer
Journal:  Epilepsia       Date:  2016-06-08       Impact factor: 5.864

5.  The phenotypic spectrum of SCN8A encephalopathy.

Authors:  Jan Larsen; Gemma L Carvill; Elena Gardella; Gerhard Kluger; Gudrun Schmiedel; Nina Barisic; Christel Depienne; Eva Brilstra; Yuan Mang; Jens Erik Klint Nielsen; Martin Kirkpatrick; David Goudie; Rebecca Goldman; Johanna A Jähn; Birgit Jepsen; Deepak Gill; Miriam Döcker; Saskia Biskup; Jacinta M McMahon; Bobby Koeleman; Mandy Harris; Kees Braun; Carolien G F de Kovel; Carla Marini; Nicola Specchio; Tania Djémié; Sarah Weckhuysen; Niels Tommerup; Monica Troncoso; Ledia Troncoso; Andrea Bevot; Markus Wolff; Helle Hjalgrim; Renzo Guerrini; Ingrid E Scheffer; Heather C Mefford; Rikke S Møller
Journal:  Neurology       Date:  2015-01-07       Impact factor: 9.910

6.  De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis.

Authors:  Kameryn M Butler; Cristina da Silva; Yuval Shafir; James D Weisfeld-Adams; John J Alexander; Madhuri Hegde; Andrew Escayg
Journal:  Epilepsy Res       Date:  2016-11-06       Impact factor: 3.045

7.  Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia.

Authors:  Olga Kopach; Noemí Esteras; Selina Wray; Dmitri A Rusakov; Andrey Y Abramov
Journal:  J Cell Sci       Date:  2020-05-27       Impact factor: 5.285

8.  Prominent role of forebrain excitatory neurons in SCN8A encephalopathy.

Authors:  Rosie K A Bunton-Stasyshyn; Jacy L Wagnon; Eric R Wengert; Bryan S Barker; Alexa Faulkner; Pravin K Wagley; Kritika Bhatia; Julie M Jones; Marissa R Maniaci; Jack M Parent; Howard P Goodkin; Manoj K Patel; Miriam H Meisler
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

9.  A gain-of-function mutation in Nav1.6 in a case of trigeminal neuralgia.

Authors:  Brian S Tanaka; Peng Zhao; Fadia B Dib-Hajj; Valerie Morisset; Simon Tate; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Mol Med       Date:  2016-08-03       Impact factor: 6.354

10.  Functional analysis of three Nav1.6 mutations causing early infantile epileptic encephalopathy.

Authors:  Laura Solé; Jacy L Wagnon; Michael M Tamkun
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-08       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.